510(k) Report

510(k) · Cleared

Cleared

BCM2-Body Composition Monitor

K250634510(k) TraditionalCleared Nov 24, 2025266-day reviewClass II21 CFR 870.2770

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Fresenius Medical Care Renal Therapies Group, LLC · DSB Plethysmograph, Impedance

Cleared on Nov 24, 2025 as substantially equivalent to K142503 (Intersection Medical, Inc., 2015) and 1 other predicate after a 266-day review. Its family tree reaches back 6 generations to 1992.

Decided
Nov 24, 2025
Review
266 days
Class
Class II
Product code
DSB
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K922218 (1992). 8 ancestors in all, the oldest K904109 (1991). No later device cites it as a predicate yet.

  1. Root · 6 generations backK922218 IQ SystemRenaissance Technology, Inc. · 1992
  2. 5 generations backK042113 Zoe Fluid Status MonitorNoninvasive Medical Technologies, LLC · 2004
  3. 4 generations backK112830 Zoefluid Status Monitor (Model Zoe 2B)Noninvasive Medical Technologies, Inc. · 2012
  4. 3 generations backK131509 Zoe Fluid Status MonitorNoninvasive Medical Technologies, Inc. · 2013
  5. 2 generations backK133301 Zoe Fluid Status MonitorNoninvasive Medical Technologies, Inc. · 2014
  6. 1 generation backK142503 Imed-Z Fluid Status MonitorIntersection Medical, Inc. · 2015
  7. This deviceK250634 BCM2-Body Composition MonitorFresenius Medical Care Renal Therapies Group, LLC · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K922218IQ SystemRenaissance Technology, Inc.1992—
−5K042113Zoe Fluid Status MonitorNoninvasive Medical Technologies, LLC2004—
−4K112830Zoefluid Status Monitor (Model Zoe 2B)Noninvasive Medical Technologies, Inc.2012—
−3K131509Zoe Fluid Status MonitorNoninvasive Medical Technologies, Inc.2013—
−2K133301Zoe Fluid Status MonitorNoninvasive Medical Technologies, Inc.2014—
−1K142503Imed-Z Fluid Status MonitorIntersection Medical, Inc.2015—
0 (this device)K250634BCM2-Body Composition MonitorFresenius Medical Care Renal Therapies Group, LLC2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199910
FIG. 1 — Lineage of K250634, 1992–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DSB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DSB device

  1. #1 K232089 SOZO Proscore 14.6 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K142503Imed-Z Fluid Status Monitor
Summary page 5
…raph, Impedance FDA Review Panel: Cardiovascular 1.3. Legally Marketed Predicate Device 1.3.1. Predicate Device – Intersection Medical Inc. IMED-Z (K142503) The predicate device for the BCM2 - Body Composition Monitor (hereinafter referred to as the “BCM2”) is the IMED-Z Fluid Status…
Intersection Medical, Inc.2015—
*K904109Bio-Impedance Analyzer
Summary page 5
…Fluid Status Monitor (K142503). The IMED-Z has not been the subject of a design-related recall. 1.3.2. Reference Device – Xitron Hydra 4000 The Xitron Hydra 4000 (K904109) is being used as a reference device to demonstrate the equivalence of technological characteristics (i.e., bioimpedance spectros…
Xitron Technologies, Inc.1991—

Also cleared against K142503: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 33 years and passes through 5 companies; a new generation was cleared every 8.2 years on median.
  • None of the 8 ancestors has a recall.
  • 2 other devices also cite its predicate K142503.

How does its category compare?

All DSB devices

DSB Plethysmograph, Impedance: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · DSB

3in 2025

2007: 22008: 62009: 22010: 12011: 22012: 12013: 22014: 22015: 22017: 22018: 12019: 12020: 22021: 12022: 12023: 22025: 32026 (partial year): 1
2007high 6 (2008) · low 0 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DSB

266in 2025

2008: 90 days median2025: 266 days median
2007high 266 (2025) · low 90 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DSB

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DSB

2in 2025

2016: 12025: 2
2007high 2 (2025) · low 0 (2007)2025

MAUDE reports naming product code DSB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
200869000
20092—00
20101—00
20112—00
20121—00
20132—00
20142—00
20152—10
20160—01
20172—00
20181—00
20191—00
20202—00
20211—00
20221—00
20232—00
20240—00
2025326602
20261—0—

What is it indicated for?

The BCM2 is intended for use, under the direction of a physician, for the noninvasive intermittent measurement of fluid status in patients with end-stage kidney disease (ESKD) including those receiving maintenance dialysis.

The device does not generate any real-time alarms and outputs from the device should be used in the context of all clinical data to assess a patient's fluid status.

The device is intended for use in patients 18 years and older.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K250634: BCM2-Body Composition Monitor.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K250634

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026